EMD Millipore Opens New R&D Center - The facility, which includes state-of-the-art formulation, analytical and synthetic laboratories as well as a customer training center, will focus on bioavaila

ADVERTISEMENT

EMD Millipore Opens New R&D Center
The facility, which includes state-of-the-art formulation, analytical and synthetic laboratories as well as a customer training center, will focus on bioavailability enhancement and oral dosage formulations.


EMD Millipore announced that it has opened a new R&D center for formulation in Darmstadt, Germany, which combines state-of-the-art formulation, analytical and synthetic laboratories and a customer training center in a single facility.

With EMD Millipore’s expertise in developing oral dosage formulations and drug delivery systems, the center will focus on addressing bioavailability and formulation challenges by using the company’s portfolio of innovative technologies and products. It will provide hands-on support to assist customers in their drug development.

EMD Millipore’s core areas are inorganic carriers, solid dispersion formulation techniques and excipients for controlled release, with technologies in granulation, tableting, film coating, direct compression and freeze drying.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here